Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.

Rodríguez-Calvo R, Girona J, Rodríguez M, Samino S, Barroso E, de Gonzalo-Calvo D, Guaita-Esteruelas S, Heras M, van der Meer RW, Lamb HJ, Yanes O, Correig X, Llorente-Cortés V, Vázquez-Carrera M, Masana L.

Metabolism. 2019 Jul;96:12-21. doi: 10.1016/j.metabol.2019.04.007. Epub 2019 Apr 15.

PMID:
30999003
2.

Palmitate decreases migration and proliferation and increases oxidative stress and inflammation in smooth muscle cells: role of the Nrf2 signaling pathway.

Girona J, Rosales R, Saavedra P, Masana L, Vallvé JC.

Am J Physiol Cell Physiol. 2019 Jun 1;316(6):C888-C897. doi: 10.1152/ajpcell.00293.2018. Epub 2019 Mar 13.

PMID:
30865473
3.

Extracellular FABP4 uptake by endothelial cells is dependent on cytokeratin 1 expression.

Martínez-Micaelo N, Rodríguez-Calvo R, Guaita-Esteruelas S, Heras M, Girona J, Masana L.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Mar;1864(3):234-244. doi: 10.1016/j.bbalip.2018.11.011. Epub 2018 Dec 3.

PMID:
30521939
4.

FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.

Bosquet A, Girona J, Guaita-Esteruelas S, Heras M, Saavedra-García P, Martínez-Micaelo N, Masana L, Rodríguez-Calvo R.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Jun;1863(6):604-613. doi: 10.1016/j.bbalip.2018.03.004. Epub 2018 Mar 15.

PMID:
29550588
5.

Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.

Rodríguez-Borjabad C, Ibarretxe D, Girona J, Ferré R, Feliu A, Amigó N, Guijarro E, Masana L, Plana N; DECOPIN Group.

Atherosclerosis. 2018 Mar;270:117-122. doi: 10.1016/j.atherosclerosis.2018.01.040. Epub 2018 Jan 31.

PMID:
29407879
6.

Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels-The zero-LDL hypothesis.

Masana L, Girona J, Ibarretxe D, Rodríguez-Calvo R, Rosales R, Vallvé JC, Rodríguez-Borjabad C, Guardiola M, Rodríguez M, Guaita-Esteruelas S, Oliva I, Martínez-Micaelo N, Heras M, Ferré R, Ribalta J, Plana N.

J Clin Lipidol. 2018 Mar - Apr;12(2):292-299.e3. doi: 10.1016/j.jacl.2017.12.018. Epub 2018 Jan 8. Review.

PMID:
29398429
7.

Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children.

Girona J, Rodríguez-Borjabad C, Ibarretxe D, Heras M, Amigo N, Feliu A, Masana L, Plana N; DECOPIN Group.

J Clin Lipidol. 2018 Jan - Feb;12(1):211-218. doi: 10.1016/j.jacl.2017.10.003. Epub 2017 Oct 12.

PMID:
29102496
8.

Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.

Guaita-Esteruelas S, Saavedra-García P, Bosquet A, Borràs J, Girona J, Amiliano K, Rodríguez-Balada M, Heras M, Masana L, Gumà J.

Oncologist. 2017 Nov;22(11):1309-1315. doi: 10.1634/theoncologist.2016-0483. Epub 2017 Jul 12.

9.

Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease.

Rodríguez-Calvo R, Girona J, Alegret JM, Bosquet A, Ibarretxe D, Masana L.

J Endocrinol. 2017 Jun;233(3):R173-R184. doi: 10.1530/JOE-17-0031. Epub 2017 Apr 18. Review.

PMID:
28420707
10.

Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases.

Girona J, Ibarretxe D, Plana N, Guaita-Esteruelas S, Amigo N, Heras M, Masana L.

Cardiovasc Diabetol. 2016 Aug 4;15(1):107. doi: 10.1186/s12933-016-0428-z.

11.

[Long-term effects of continuous positive airway pressure treatment on subclinical atherosclerosis in obstructive sleep apnoea syndrome].

Català R, Ferré R, Cabré A, Girona J, Porto M, Texidó A, Masana L.

Med Clin (Barc). 2016 Jul 1;147(1):1-6. doi: 10.1016/j.medcli.2016.03.032. Spanish.

PMID:
27210810
12.

Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells.

Bosquet A, Guaita-Esteruelas S, Saavedra P, Rodríguez-Calvo R, Heras M, Girona J, Masana L.

Atherosclerosis. 2016 Jun;249:191-9. doi: 10.1016/j.atherosclerosis.2016.04.012. Epub 2016 Apr 14.

PMID:
27155388
13.

Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins.

Guaita-Esteruelas S, Bosquet A, Saavedra P, Gumà J, Girona J, Lam EW, Amillano K, Borràs J, Masana L.

Mol Carcinog. 2017 Jan;56(1):208-217. doi: 10.1002/mc.22485. Epub 2016 Apr 6.

14.

Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders.

Ibarretxe D, Girona J, Amigó N, Plana N, Ferré R, Guaita S, Mallol R, Heras M, Masana L.

J Clin Lipidol. 2016 Mar-Apr;10(2):330-8.e2. doi: 10.1016/j.jacl.2015.12.012. Epub 2015 Dec 22.

PMID:
27055964
15.

Serum palmitoleate acts as a lipokine in subjects at high cardiometabolic risk.

Merino J, Sala-Vila A, Plana N, Girona J, Vallve JC, Ibarretxe D, Ros E, Ferré R, Heras M, Masana L.

Nutr Metab Cardiovasc Dis. 2016 Mar;26(3):261-7. doi: 10.1016/j.numecd.2015.12.008. Epub 2015 Dec 28.

PMID:
26817937
16.

Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders.

Ibarretxe D, Girona J, Plana N, Cabré A, Ferré R, Amigó N, Guaita S, Mallol R, Heras M, Masana L.

Clin Investig Arterioscler. 2016 Mar-Apr;28(2):71-8. doi: 10.1016/j.arteri.2015.11.001. Epub 2015 Dec 29.

PMID:
26743379
17.

Correction: FABP4 Induces Vascular Smooth Muscle Cell Proliferation and Migration through a MAPK-Dependent Pathway.

Girona J, Rosales R, Plana N, Saavedra P, Masana L, Vallvé JC.

PLoS One. 2016 Jan 5;11(1):e0146632. doi: 10.1371/journal.pone.0146632. eCollection 2016. No abstract available.

18.

Body mass index correlates with atherogenic lipoprotein profile even in nonobese, normoglycemic, and normolipidemic healthy men.

Guardiola M, Solà R, Vallvé JC, Girona J, Godàs G, Heras M, Gonzàlez M, Rock E, Winklhoffer-Roob BM, Masana L, Ribalta J.

J Clin Lipidol. 2015 Nov-Dec;9(6):824-831.e1. doi: 10.1016/j.jacl.2015.08.001. Epub 2015 Aug 7.

PMID:
26687704
19.

New insights into circulating FABP4: Interaction with cytokeratin 1 on endothelial cell membranes.

Saavedra P, Girona J, Bosquet A, Guaita S, Canela N, Aragonès G, Heras M, Masana L.

Biochim Biophys Acta. 2015 Nov;1853(11 Pt A):2966-74. doi: 10.1016/j.bbamcr.2015.09.002. Epub 2015 Sep 4.

20.

FABP4 plasma concentrations are determined by acquired metabolic derangements rather than genetic determinants.

Ibarretxe D, Girona J, Plana N, Cabré A, Heras M, Ferré R, Merino J, Vallvé JC, Masana L.

Nutr Metab Cardiovasc Dis. 2015 Sep;25(9):875-80. doi: 10.1016/j.numecd.2015.05.008. Epub 2015 Jun 11.

PMID:
26141940
21.

Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients.

Masana L, Cabré A, Heras M, Amigó N, Correig X, Martínez-Hervás S, Real JT, Ascaso JF, Quesada H, Julve J, Palomer X, Vázquez-Carrera M, Girona J, Plana N, Blanco-Vaca F.

Atherosclerosis. 2015 Feb;238(2):213-9. doi: 10.1016/j.atherosclerosis.2014.12.006. Epub 2014 Dec 9.

PMID:
25528430
22.

Physical activity below the minimum international recommendations improves oxidative stress, ADMA levels, resting heart rate and small artery endothelial function.

Merino J, Ferré R, Girona J, Aguas D, Cabré A, Plana N, Vinuesa A, Ibarretxe D, Basora J, Buixadera C, Masana L.

Clin Investig Arterioscler. 2015 Jan-Feb;27(1):9-16. doi: 10.1016/j.arteri.2014.04.004. Epub 2014 Aug 10.

PMID:
25112554
23.

[Interaction of FABP4 with plasma membrane proteins of endothelial cells].

Saavedra P, Girona J, Aragonès G, Cabré A, Guaita S, Heras M, Masana L.

Clin Investig Arterioscler. 2015 Jan-Feb;27(1):26-33. doi: 10.1016/j.arteri.2014.05.003. Epub 2014 Jul 16. Spanish.

PMID:
25037742
24.

Reversal of hyperoxaluric cardiomyopathy with severe cardiac dysfunction after combined liver and kidney transplantation.

Giralt G, Madrid Á, Garrido M, Albert DC, Betrian P, Girona J.

Rev Esp Cardiol (Engl Ed). 2013 Mar;66(3):224-5. doi: 10.1016/j.rec.2012.06.018. Epub 2012 Sep 25. No abstract available.

PMID:
24775460
25.

Increasing long-chain n-3PUFA consumption improves small peripheral artery function in patients at intermediate-high cardiovascular risk.

Merino J, Sala-Vila A, Kones R, Ferre R, Plana N, Girona J, Ibarretxe D, Heras M, Ros E, Masana L.

J Nutr Biochem. 2014 Jun;25(6):642-6. doi: 10.1016/j.jnutbio.2014.02.004. Epub 2014 Mar 12.

PMID:
24746829
26.

Low-carbohydrate, high-protein, high-fat diet alters small peripheral artery reactivity in metabolic syndrome patients.

Merino J, Kones R, Ferré R, Plana N, Girona J, Aragonés G, Ibarretxe D, Heras M, Masana L.

Clin Investig Arterioscler. 2014 Mar-Apr;26(2):58-65. doi: 10.1016/j.arteri.2013.11.004. Epub 2013 Dec 21.

PMID:
24365581
27.

FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway.

Girona J, Rosales R, Plana N, Saavedra P, Masana L, Vallvé JC.

PLoS One. 2013 Nov 29;8(11):e81914. doi: 10.1371/journal.pone.0081914. eCollection 2013. Erratum in: PLoS One. 2016;11(1):e0146632.

28.

Even low physical activity levels improve vascular function in overweight and obese postmenopausal women.

Merino J, Ferré R, Girona J, Aguas D, Cabré A, Plana N, Vinuesa A, Ibarretxe D, Basora J, Buixadera C, Masana L.

Menopause. 2013 Oct;20(10):1036-42. doi: 10.1097/GME.0b013e31828501c9.

PMID:
23481124
29.

Substituting non-HDL cholesterol with LDL as a guide for lipid-lowering therapy increases the number of patients with indication for therapy.

Masana L, Ibarretxe D, Heras M, Cabré A, Ferré R, Merino J, Plana N, Girona J.

Atherosclerosis. 2013 Feb;226(2):471-5. doi: 10.1016/j.atherosclerosis.2012.12.001. Epub 2012 Dec 19.

PMID:
23290265
30.

Body weight loss by very-low-calorie diet program improves small artery reactive hyperemia in severely obese patients.

Merino J, Megias-Rangil I, Ferré R, Plana N, Girona J, Rabasa A, Aragonés G, Cabré A, Bonada A, Heras M, Masana L.

Obes Surg. 2013 Jan;23(1):17-23. doi: 10.1007/s11695-012-0729-6.

PMID:
22918551
31.

Negative effect of a low-carbohydrate, high-protein, high-fat diet on small peripheral artery reactivity in patients with increased cardiovascular risk.

Merino J, Kones R, Ferré R, Plana N, Girona J, Aragonés G, Ibarretxe D, Heras M, Masana L.

Br J Nutr. 2013 Apr 14;109(7):1241-7. doi: 10.1017/S0007114512003091. Epub 2012 Jul 31.

PMID:
22850317
32.

Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells.

Aragonès G, Saavedra P, Heras M, Cabré A, Girona J, Masana L.

Cardiovasc Diabetol. 2012 Jun 18;11:72. doi: 10.1186/1475-2840-11-72.

33.

Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trial.

Solà R, Valls RM, Godàs G, Perez-Busquets G, Ribalta J, Girona J, Heras M, Cabré A, Castro A, Domenech G, Torres F, Masana L, Anglés N, Reguant J, Ramírez B, Barriach JM.

PLoS One. 2012;7(2):e31103. doi: 10.1371/journal.pone.0031103. Epub 2012 Feb 27.

34.

Extended Szabo (anchor-wire) technique concept for stent implantation in congenital heart lesions.

Girona J, Martí G, Betrian P, García B.

Pediatr Cardiol. 2012 Oct;33(7):1089-96. doi: 10.1007/s00246-012-0231-x. Epub 2012 Feb 24.

PMID:
22361739
35.

Lifestyle changes lower FABP4 plasma concentration in patients with cardiovascular risk.

Lázaro I, Ferré R, Plana N, Aragonès G, Girona J, Merino J, Heras M, Cabré A, Masana L.

Rev Esp Cardiol (Engl Ed). 2012 Feb;65(2):152-7. doi: 10.1016/j.recesp.2011.09.016. Epub 2011 Dec 5. English, Spanish.

PMID:
22153726
36.

Heterozygous familial hypercholesterolaemic patients have increased arterial stiffness, as determined using the augmentation index.

Plana N, Ferré R, Merino J, Aragonès G, Girona J, Heras M, Masana L.

J Atheroscler Thromb. 2011;18(12):1110-6. Epub 2011 Dec 1.

37.

[Non-compacted cardiomyopathy: clinical characteristics, evolution and prognostic data in childhood. Results of a multicenter study].

Sabaté Rotés A, Huertas-Quiñones VM, Betrián P, Carretero J, Jiménez L, Girona J, Uriel S, Perich R, Collell R, Prada F, Albert DC.

An Pediatr (Barc). 2012 Dec;77(6):360-5. doi: 10.1016/j.anpedi.2011.08.005. Epub 2011 Nov 26. Spanish.

38.

[Cardiopulmonary stress testing in children who have had congenital heart disease surgery. Physical exercise recommendations during school hours].

Serra-Grima R, Doñate M, Borrás X, Rissech M, Puig T, Albert DC, Bartrons J, Gran F, Manso B, Ferrer Q, Girona J, Casaldáliga J, Subirana M.

Rev Esp Cardiol. 2011 Sep;64(9):780-7. doi: 10.1016/j.recesp.2011.05.007. Epub 2011 Jul 19. Spanish.

39.

Small artery dilation and endothelial markers in cardiovascular risk patients.

Aragonès G, Ferré R, Girona J, Plana N, Merino J, Heras M, Masana L.

Eur J Clin Invest. 2012 Jan;42(1):34-41. doi: 10.1111/j.1365-2362.2011.02553.x. Epub 2011 Jun 1.

PMID:
21631467
40.

APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrate.

Guardiola M, Alvaro A, Vallvé JC, Rosales R, Solà R, Girona J, Serra N, Duran P, Esteve E, Masana L, Ribalta J.

Nutr Metab Cardiovasc Dis. 2012 Sep;22(9):756-62. doi: 10.1016/j.numecd.2010.12.003. Epub 2011 Apr 13.

PMID:
21489765
41.

Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes.

Aragonès G, Ferré R, Lázaro I, Cabré A, Plana N, Merino J, Heras M, Girona J, Masana L.

Atherosclerosis. 2010 Nov;213(1):329-31. doi: 10.1016/j.atherosclerosis.2010.07.026. Epub 2010 Jul 27.

PMID:
20723896
42.

Effects of therapeutic lifestyle changes on peripheral artery tonometry in patients with abdominal obesity.

Ferré R, Plana N, Merino J, Aragonès G, Girona J, Heras M, Coll B, Cos R, Masana L.

Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):95-102. doi: 10.1016/j.numecd.2010.04.008. Epub 2010 Aug 12.

PMID:
20708393
43.

Effect of the long-term regular intake of virgin olive oil on the phenolic metabolites in human fasting plasma.

Valls RM, Soler A, Girona J, Heras M, Romero MP, Covas MI, Solà R, Masana L, Motilva MJ.

J Pharm Biomed Anal. 2010 Sep 21;53(1):68-74. doi: 10.1016/j.jpba.2010.03.006. Epub 2010 Mar 11.

PMID:
20359841
44.

APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome.

Castro A, Lázaro I, Selva DM, Céspedes E, Girona J, NúriaPlana, Guardiola M, Cabré A, Simó R, Masana L.

Atherosclerosis. 2010 Mar;209(1):201-5. doi: 10.1016/j.atherosclerosis.2009.09.072. Epub 2009 Oct 6.

PMID:
19878946
45.

The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.

Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Guardiola M, Heras M, Masana L.

Nutr Metab Cardiovasc Dis. 2010 May;20(4):243-8. doi: 10.1016/j.numecd.2009.04.003. Epub 2009 Sep 17.

PMID:
19765959
46.

Percutaneous implantation of a pulmonary valve.

Girona J, Betrián P, Martí G.

Rev Esp Cardiol. 2009 Sep;62(9):1072-4. English, Spanish. No abstract available.

47.

Percutaneous embolization of vascular fistulas using coils or Amplatzer vascular plugs.

Girona J, Martí G, Betrián P, Gran F, Casaldàliga J.

Rev Esp Cardiol. 2009 Jul;62(7):765-73. English, Spanish.

48.

Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis.

Vallvé JC, Paredes S, Girona J, Uliaque K, Ribalta J, Hurt-Camejo E, Masana L.

J Rheumatol. 2008 Sep;35(9):1697-703. Epub 2008 Jul 15.

PMID:
18634161
49.

Factors involved in alleviating water stress by partial crop removal in pear trees.

Marsal J, Mata M, Arbones A, Del Campo J, Girona J, Lopez G.

Tree Physiol. 2008 Sep;28(9):1375-82.

PMID:
18595850
50.

Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes.

Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Heras M, Masana L.

J Lipid Res. 2008 Aug;49(8):1746-51. doi: 10.1194/jlr.M800102-JLR200. Epub 2008 Apr 17.

Supplemental Content

Loading ...
Support Center